NanoVibronix Inc. Announces New Patent Award, Strengthening Leadership in Medical Navigation Technology
NanoVibronix Inc. has announced the issuance of U.S. Patent No. 12,409,105 B2, entitled "Insertion Device Positioning Guidance System and Method," to its subsidiary, ENvue Medical Holdings LLC. The patent, issued by the United States Patent and Trademark Office on September 9, 2025, strengthens NanoVibronix's intellectual property portfolio in medical navigation technology. This development is expected to enhance the company's competitive edge by protecting proprietary systems and methods that improve the accuracy and safety of medical device insertion using electromagnetic positioning technology. The patent aims to reduce risks and improve procedural efficiency for clinicians.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoVibronix Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250915498756) on September 15, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。